Supplemental Material and Methods

Patients and study design
The patients included were formally informed and agreed to participate in the study. The protocol was approved by the local hospital committees in agreement with the human rights legislation from the Declaration of Helsinki. Patients underwent dialysis with fiber super high-flux dialyzers (NIKKISO-Medical GmbH, Hamburg, Germany) or capillary low-flux dialyzers (Xenium-LF, Baxter Hellas, Athens, Greece) with γ-sterilized biocompatible polyethersulfone membrane. Dialyzers were heparinized with low molecular-weight heparin as anticoagulant. Patients received an infusion of iron sucrose (Venofer, Vifor France SA, France) during the last 30 minutes of hemodialysis session. Samples were collected 15 min before the initiation and 15 min after the termination of iron administration. In time-course experiments, samples were collected at different time points after iron administration (0, 1, 2, 3, 5, 7, and 9 hours).
Whole blood samples were collected and a part was used for hematological analysis while the rest was used for isolation of serum and standardized routine laboratory analyses. A part of serum was frozen at -20 0 C until further analysis for Tf-Sat by U-PAGE and hepcidin concentration by ELISA.
Estimation of Tf-Sat(%) by U-PAGE
Different transferrin forms were separated and visualized by using a slightly modified methodology, the U-PAGE that was previously described by Makey and Seal. 1 This methodology separates transferrin into its apo-form, the two monoferric C-and Nforms, and the diferric form, according to their electrophoretic mobilities in 6% polyacrylamide gels containing high concentration of urea (6 M). The proteins in the gel were stained with Coomassie brilliant blue R-250 and densitometric image analysis was performed by Quantity One ® 1-D analysis software (Bio-Rad Laboratories, CA, US). The relative amount of transferrin saturation was calculated by using the following equation:
Serum transferrin forms could be efficiently separated in U-PAGE gels on the condition that the balk of the rest of serum proteins should be precipitated by incubating the samples with Rivanol.
Serum hepcidin measurement
Quantification of secreted hepcidin levels in sera was performed blindly by competitive ELISA, as previously described. 2 Each well was coated with purified recombinant Hepcidin25-His (0.5 µg/ml, at 4ºC for 16 hours). Diluted patient sera (1/8) were incubated with the polyclonal antibody, for 16 h at 4ºC. The complexes formed were added to the coated wells and incubated for 1 h at 37ºC. A goat antirabbit, IgG-horseradish peroxidase conjugate was added and the mixture was incubated at 37°C for 1 h before the addition of tetramethylbenzidine (TMB) reagent. Optical densities were measured by a microplate reader at 450 nm.
Statistical analysis
All data are presented as mean ± SD. The paired Mann-Whitney U-Test Student's ttest was used to assess differences between the various parameters before and after dialysis. The association between different parameters was calculated using a nonparametric Spearman rank correlation.
